EJNMMI Research

Article	Citations
18 F-Choline-PET/CT for non-FDG-avid salivary gland cancer: a preliminary report	54
Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods	43
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, n	36
Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging	35
Biodistribution and dosimetry of the PET radioligand [18F]CHDI-650 in mice for detection of mutant huntingtin aggregates	33
18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer	32
Influence of corticosteroid treatment on CXCR4 expression in DLBCL	31
18F-FAPI PET/CT imaging in pneumoconiosis: a pilot study on a novel tool for early diagnosis and guiding the treatment of pulmonary fibrosis	30
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism	29
Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer	27
[18F]F-FES PET for diagnosis, staging, and endocrine therapy prediction in ER-positive breast cancer: a systematic review and meta-analysis	27
Predicting overall survival in pancreatic ductal adenocarcinoma using 18F-FDG PET/CT radiomics: a two-center study​	24
Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation	23
Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study	23
Hypometabolism and atrophy patterns associated with Niemann-Pick type C	22
The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma	21
Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [18F]FDG PET/CT in patients with type 2 diabetes	21
Relationship between absorbed dose and SUV derived from SPECT/CT imaging and dose-response in patients with neuroendocrine tumors treated with [¹⁷⁷Lu]Lu-DOTA-TATE	21
Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?	20
Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases	19
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling	18
Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression	18
Radiation dosimetry and fasting-dependent hepatobiliary clearance of the VAChT-specific PET radioligand 18F-VAT in humans	17
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A	16
First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study	16

Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model	16
Establishment and validation of a clinical threshold criteria for choosing PET imaging tracers for indolent non-Hodgkin’s lymphoma	15
Beyond bisphosphonates: radiolabeled phosphopeptides for bone targeting	15
All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful	15
Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with 212Pb alpha-radioimmunotherapy targeting CD20	15
Correction: Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission co	15
Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein	15
Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI – a comparative study	15
Association of white matter injury and neuroinflammation in the post-acute phase after ischemic stroke using [18F]FEPPA-PET/MRI	15
Hepatobiliary PET with [68Ga]Ga-BP-IDA – preclinical evaluation and its translational potential for liver function monitoring	14
Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma	14
Quantitative renal [99mTc]DMSA imaging predicts urinary [99mTc]DMSA excretion in patients with chronic kidney disease	14
A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points	13
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval	13
TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity	13
A phase II study evaluating pharmacokinetics and dosimetry of 177Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer	13
Autoradiographic comparison between [11C]PiB and [18F]AZD4694 in human brain tissue	13
Multi-organ glucose metabolism alterations in diabetes mellitus: a total-body 18F-FDG PET/CT study	13
[18F]Fluorocholine PET/CT in a 15-year-old patient suggested HPT-JT syndrome with active cemento-ossifying fibroma	13
CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue	13
The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2	12
PET imaging of GABAA receptors in pancreatic islets by [11C]flumazenil	12
MRI ensemble model of plaque and perivascular adipose tissue as PET-equivalent for identifying carotid atherosclerotic inflammation	12
Molecular imaging in hypertrophic cardiomyopathy: an exploratory study with 2-[18F]FDG and [13N]NH3	12
Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response	12
First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor	12
Ultrasensitive detection of uveal melanoma using [18F]AlF-NOTA-PRGD2 PET imaging	12
A dual-tracer approach using [11C]CH and [18F]FDG in HCC clinical decision making	12
Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry	12
Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism	12
Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer’s disease-related pattern	11
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer	11
Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients	11
Reorganization of brain connectivity in post-COVID condition: a 18F-FDG PET study	11
Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer	11
Magnetic resonance spectroscopy for enhanced multiparametric MRI characterization of [18F]FET PET-negative gliomas	11
Repeatability of tumour perfusion measurement with [15O]H2O PET in prostate cancer	11
[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma	11
Fc-engineered monoclonal antibodies to reduce off-target liver uptake	11
Quantification in respiratory-gated PET acquisition: can data-driven methods replace device-based systems?—a comparative and retrospective study	10
The effect of androgen blockade on [68Ga]Ga-PSMA-11 and [18F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging study	10
Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer	10
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides	10
Preclinical in vivo dosimetry of healthy tissues in radiopharmaceutical therapy: implementation of a physiologically realistic mouse eye model in GATE	10
Characterization of in vivo binding kinetics and non-displaceable binding of [18F]SynvesT-1 in the rat brain	10
Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer	10
A study method using early dynamic acquisition of [18F]fluorodopa positron emission tomography for the differential diagnosis between progression and radionecrosis of brain metastases after radiothera	10
Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies	10
Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery	9
Comparison between [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT uptake in luminal-like vs. HER2-positive breast cancer	9

Reduced hematopoietic-inflammatory response and worse outcomes in patients with recurrent myocardial infarction in comparison with primary myocardial infarction	9
Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis	9
Imaging renal mitochondrial dysfunction in chronic kidney disease: a repurposed role for [99mTc]Tc-MIBI SPECT/CT	9
Distinguishing lymphoma from benign lymph node diseases in fever of unknown origin using PET/CT radiomics	9
Phantom and clinical evaluation of the effect of a new Bayesian penalized likelihood reconstruction algorithm (HYPER Iterative) on 68Ga-DOTA-NOC PET/CT image quality	9
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases	9
Quantitative terbium-161 SPECT/CT imaging: demonstrating the feasibility of image-based dosimetry and highlighting pitfalls	9
68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism	9
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D	9
Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study	9
EJNMMI research: a vision for the next era of nuclear medicine	8
[18F]F-FAPI-74 PET/CT for gonadal and extragonadal germ cell Tumors: a pilot study	8
[18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice	8
68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study	8
Exploring the impact of PEGylation on pharmacokinetics: a size-dependent effect of polyethylene glycol on prostate-specific membrane antigen inhibitors	8
Effect of radiation therapy on lymph node fluorescence in head and neck squamous cell carcinoma after intravenous injection of indocyanine green: a prospective evaluation	8
Blood-based transcriptomic biomarkers for response to [177Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors	8
Characterisation of a novel [18F]FDG brain PET database and combination with a second database for optimising detection of focal abnormalities, using focal cortical dysplasia as an example	8
Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation	8
3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy	8
Accuracy of dynamic sentinel lymph node biopsy for inguinal lymph node staging in cN0 penile cancer	8
[18F]FDG PET-MR characterization of aortitis in the IL1rn−/− mouse model of giant-cell arteritis	8
Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells	8
Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids	8
Light up heart-type fatty acid binding protein (FABP3) with a novel fluorine-18 labelled selective FABP3 ligand	8
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations	8
Total-body 18F-FDG PET/CT: more choices to promote clinical scanning efficiency	8
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease	8
Tumor sink effect on melanin-ligand [131I]ICF01012 in melanoma and its implications for targeted radionuclide therapy	8
Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET	8
Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells	8
Diagnostic and prognostic value of myocardial flow reserve quantification with single photon emission computed tomography – a systematic review and meta-analysis	7
A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors	7
[195mPt]Cisplatin for lung cancer imaging: a pilot study	7
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients	7
Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms	7
Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours	7
A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma	7
Impact of brain segmentation methods on regional metabolism quantification in 18F-FDG PET/MR analysis	7
Myocardial glucose suppression may interfere with the detection of inflammatory cells with FDG-PET as suggested in a canine model of myocardial infarction	7
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging	7
99mTc-Labeled FAPI SPECT and 18F-FDG PET imaging for visualization and evaluation of connective tissue disease-associated interstitial lung disease	7
Metabolic phenotyping of hand automatisms in mesial temporal lobe epilepsy	6
Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses	6
Evaluation of ultrasonographic and clinicopathological features of patients with abnormal [68Ga]Ga-DOTA-TATE uptake in the thyroid gland	6
AI may help to predict thyroid nodule malignancy based on radiomics features from [18F]FDG PET/CT	6
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors	6
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)	6
Myocardial perfusion and oxidative metabolism in healthy subjects: sex-specific insights from vasodilatory stress 11C-acetate PET	6
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model	6
Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)	6
Effect of cerebral sinus venous thrombosis and its location on cerebral blood flow: a [15O]water PET study in acute stroke patients compared to healthy volunteers	6
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy	6
Feasibility of a drop-in γ-probe for radioguided sentinel lymph detection in early-stage cervical cancer	6
A robust and versatile deep learning model for prediction of the arterial input function in dynamic small animal [18F] FDG PET imaging	5
Data-driven identification and semi-automated quantification of molecular targets for tumour-imaging of colorectal liver metastases and primary colorectal tumours	5
The remodeling of metabolic brain pattern in patients with extracranial diffuse large B-cell lymphoma	5
The assessment of left ventricular volume and function in gated small animal 18F-FDG PET/CT imaging: a comparative study of three commercially available software tools	5
Brown adipose tissue machine learning nnU-Net V2 network using TriDFusion (3DF)	5
18F-ASEM PET/MRI targeting alpha7-nicotinic acetylcholine receptor can reveal skeletal muscle denervation	5
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer	5
The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer	5
Autoradiographic assessment of SynVesT-1 revealed changes in non-displaceable binding with demyelination and remyelination: implications for SV2A PET analysis	5
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study	5
Evaluation of a clinically efficient [18F]FDG PET/CT protocol: short dynamic and two-phase static imaging for differentiating malignant pulmonary lesions	5
Variability of the arterial input function in small-animal dynamic PET imaging	5
Is CXCR4-targeted 68Ga-pentixafor PET/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions?	5
Kinetics of the amino acid uptake tracer O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in human brain	5
Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging	5
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation	5
Non-invasive visualization of pH changes within the tumor-micro-environment by positron emission tomography	5
Neuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease	5
Utility of quantitative standardized uptake value from pre-operative bone SPECT/CT for predicting post-surgical MRONJ healing response	5
Model selection for dynamic PET compartmental modelling of 18F-FDG uptake using a long axial field-of-view PET scanner with delay and motion correction	5
A peptide nucleic acid-based pretargeting approach using 161Tb for radionuclide therapy in a murine tumor model	5
Comparative benefits of Ki and SUV images in lesion detection during PET/CT imaging	5
Radiation protection considerations with [89Zr]Zr-girentuximab PET and surgery	5
Evaluation of [11C]UCB-A positron emission tomography in human brains	5
The effect of butylscopolamine on [18F]FDG uptake in the gastrointestinal tract is negligible and regionally variable	5
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers	5

Peptide-based PET imaging agent of tumor TIGIT expression	5
Non-invasive quantification of 18F-florbetaben with total-body EXPLORER PET	5